You are here
-
PSAP (Prostatic or Prostate Specific Acid Phosphatase) [EPR4067]
Description Prostatic Acid Phosphatase (PAP), a member of the histidine acid phosphatase family, is an enzyme that is a major component of prostatic fluid and secreted by the epithelial cells of the prostate gland. PAP labels normal prostate epithelial cells, hyperplastic and cancer cells of prostate. It is helpful in identification of tumors with prostate origin. (Shipping Cost: €200.00) Host Rabbit Application Immunohistochemistry (IHC) Reactivity Human -
PSAP (Prostatic or Prostate Specific Acid Phosphatase) [PASE/4LJ]
Description Prostate Specific Acid Phosphatase (PSAP) is a 100 kD glycoprotein present in high concentration in the prostate gland and its secretions. PSAP is measured clinically because its level often rises in the serum in cases of prostatic carcinoma. By immunohistochemical analysis PSAP has been found concentrated within the large secretory vacuoles of the supranuclear portion of the prostatic columnar epithelial cell. In hyperplastic prostates and in benign prostatic tissue adjacent to the prostatic carcinoma, PSAP activity is limited to the acinar or ductal columnar epithelial cells and adjacent luminal content. PSAP reactivity in an extraprostatic tumor is an accurate and sensitive indicator of metastatic prostatic carcinoma. (Shipping Cost: €200.00) Host Mouse Application Flow cytometry (FC), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC) Reactivity Human -
PSAP (Prostatic or Prostate Specific Acid Phosphatase) [PASE/4LJ]
Description Prostate Specific Acid Phosphatase (PSAP) is a 100 kD glycoprotein present in high concentration in the prostate gland and its secretions. PSAP is measured clinically because its level often rises in the serum in cases of prostatic carcinoma. By immunohistochemical analysis PSAP has been found concentrated within the large secretory vacuoles of the supranuclear portion of the prostatic columnar epithelial cell. In hyperplastic prostates and in benign prostatic tissue adjacent to the prostatic carcinoma, PSAP activity is limited to the acinar or ductal columnar epithelial cells and adjacent luminal content. PSAP reactivity in an extraprostatic tumor is an accurate and sensitive indicator of metastatic prostatic carcinoma. (Shipping Cost: €200.00) Host Mouse Application Flow cytometry (FC), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (IHC) Reactivity Human -
PSMA [MD105R]
Description Prostate-specific membrane antigen (PSMA), also known as folate hydrolase 1(FOLH1), is a type II transmembrane glycoprotein belonging to the M28 peptidase family. PSMA has two enzymatic activities, one as a prostate-specific integral membrane folate hydrolase and the other as a carboxypeptidase Anti-PSMA labels normal prostate epithelial cells and prostate tumor cells. Although the expression of PSMA in neovasculature of a variety of solid tumors has been reported, PSMA expression is highly restricted to the prostate. It is a useful marker for prostate tumors. In prostate cancer, overexpression of PSMA is correlated with high tumor grade, non-diploid tumors, and advanced tumor stage. It can be used as an effective predictor for tumor progression in prostate cancer (Shipping Cost: €200.00) Host Rabbit Application Immunohistochemistry (IHC) Reactivity Human -
PSMA [MD105R]
Description Prostate-specific membrane antigen (PSMA), also known as folate hydrolase 1(FOLH1), is a type II transmembrane glycoprotein belonging to the M28 peptidase family. PSMA has two enzymatic activities, one as a prostate-specific integral membrane folate hydrolase and the other as a carboxypeptidase Anti-PSMA labels normal prostate epithelial cells and prostate tumor cells. Although the expression of PSMA in neovasculature of a variety of solid tumors has been reported, PSMA expression is highly restricted to the prostate. It is a useful marker for prostate tumors. In prostate cancer, overexpression of PSMA is correlated with high tumor grade, non-diploid tumors, and advanced tumor stage. It can be used as an effective predictor for tumor progression in prostate cancer (Shipping Cost: €200.00) Host Rabbit Application Immunohistochemistry (IHC) Reactivity Human -
PTEN [6H2.1]
Description The PTEN protein is a lip phosphatase with tumor-suppressing abilities. Reduced of PTEN has been reported in a variety of malignancies, including breast, prostate, and endometrial cancer. In breast and prostate cancer, loss of PTEN expression has been shown to correlate positively with advanced stage cancer. (Shipping Cost: €200.00) Host Mouse Application Immunohistochemistry (IHC) Reactivity Human -
PTEN [6H2.1]
Description The PTEN protein is a lip phosphatase with tumor-suppressing abilities. Reduced of PTEN has been reported in a variety of malignancies, including breast, prostate, and endometrial cancer. In breast and prostate cancer, loss of PTEN expression has been shown to correlate positively with advanced stage cancer. (Shipping Cost: €200.00) Host Mouse Application Immunohistochemistry (IHC) Reactivity Human -
RANKL/CD254 Polyclonal
Description RANKL or CD254 is expressed highest in the peripheral lymph nodes, weak in spleen, peripheral blood Leukocytes, bone marrow, heart, placenta, skeletal muscle, stomach and thyroid. Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy. (Shipping Cost: €200.00) Host Rabbit Application Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB) Reactivity Human, Mouse, Rat -
RANKL/CD254 Polyclonal
Description RANKL or CD254 is expressed highest in the peripheral lymph nodes, weak in spleen, peripheral blood Leukocytes, bone marrow, heart, placenta, skeletal muscle, stomach and thyroid. Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy. (Shipping Cost: €200.00) Host Rabbit Application Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB) Reactivity Human, Mouse, Rat -
RAS (G12D Mutant Specific) Polyclonal
Description The guanine-nucleotide binding protein (K-Ras, H-Ras, and N-Ras) is 21 kDa membrane-associated GTPase which cycles between active (GTP-bound) and inactive (GDP-bound) forms, regulates cell proliferation, differentiation, and survival. Receptor tyrosine kinases and G protein-coupled receptors activate Ras, which then stimulates the Raf-MEK-MAPK pathway. GTPase-activating proteins (GAP) normally facilitate the inactivation of Ras. However, studies show that in 30% of human cancers, point mutations in Ras prevent the GAP-mediated inhibition of this pathway. The most common oncogenic Ras mutation is Gly12 to Asp12 (G12D) – Ras missense mutations at the codon 12, which results in decreased GTPase activity and constitutive signaling, possibly by increasing the overall rigidity of the protein. (Shipping Cost: €200.00) Host Rabbit Application Immunohistochemistry (IHC), Western Blot (WB) Reactivity Human